⌘K

Home/Filings/4/0001213900-25-050016

4//SEC Filing

Goodman Tony 4

Accession 0001213900-25-050016

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:01 PM ET

Size

5.6 KB

Accession

0001213900-25-050016

Insider Transaction Report

Form 4

Period: 2025-05-29

ADIAL PHARMACEUTICALS, INC.ADIL

DirectorChief Operating Officer

Transactions

Award
Stock Option (Right to Buy)
2025-05-29+94,000→ 94,000 total
Exercise: $0.69Exp: 2035-05-28→ Common Stock (94,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001717971

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 4:01 PM ET
Size: 5.6 KB

View on SEC.gov